Blood-sugar control approaches its ceiling below the weight-loss dose
You're likely a reasonable candidate if: You've been symptomatic for more than 12 weeks with confirmed or highly probable prior SARS-CoV-2 infection Standard care has not produced adequate improvement You have a clear symptom cluster that maps to one or more of the mechanisms above You're willing to undergo baseline labs and ongoing clinical monitoring You understand that peptide therapy is an emerging not established intervention for this indication You may need to address other issues first if: Active autoimmune conditions are not yet stabilised You have unmanaged cardiovascular disease You're currently immunosuppressed for another reason You haven't yet tried evidence-based long COVID rehabilitation approaches The most important step is working with a clinician who understands both long COVID pathophysiology and peptide pharmacology not one who simply offers a generic protocol

Our GLP-1 ID program applies these learnings by combining individualized GLP-1 dosing with ongoing medical guidance, personalized support, and resources designed to help patients manage side effects, stay consistent with treatment, and build sustainable habits for long-term health
It helps improve memory, learning abilities, and muscle control, which are all important for our overall well-being
The options may be chosen on the product page Peptide Research Overview Across scientific disciplines, peptide research supports advances in biochemistry and molecular biology
Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells